DL
Therapeutic Areas
Qubit Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KAT6A | Oncology | Discovery |
| IL4R | Inflammation | Discovery |
| RAS/RAF | Oncology | Discovery |
| TREX1/STING Pathway | Inflammation | Discovery |
| Undisclosed GPCR | Multiple | Discovery |
| USP7 | Oncology | Discovery |
| MRas | Oncology | Discovery |
| Undisclosed Metalloenzyme | Oncology | Discovery |